Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Janus kinase and microtubule-interacting protein 3 (JAKMIP3)
- Target
- JAKMIP3
- Molecular classification
- Other (microtubule-binding protein), Protein coding gene
01
Overview
Janus kinase and microtubule-interacting protein 3 (JAKMIP3) is a protein coding gene whose product is predicted to enable microtubule binding and kinase binding activity and is localized to the Golgi apparatus and cell membrane. Its aliases reflect historical naming conventions and gene symbols. It shares some sequence similarity with the JAKMIP1 family member but is distinct from recognized Janus kinases (JAK1-3, TYK2), which are established therapeutic targets. To date, there is no evidence supporting JAKMIP3 as a disease-related gene nor any interacting drugs; it is annotated as a structural or trafficking protein with roles potentially relevant to cellular architecture. If you require standardized structured data on JAKMIP3, note that it is not currently considered a therapeutic target, biomarker, or drug target in clinical or research contexts.
- Other names
- Neuroendocrine long coiled-coil protein 2Neuroendocrine long coiled-coil 2C10orf14C10orf39JAMIP3NECC2FLJ37857KIAA4091bA140A10.5Jakmip36330417G02Rik
02
Biological functions
Kinase bindingMicrotubule bindingLikely roles in intracellular trafficking or cellular structure
03
Disease associations
Other (no established association with major diseases based on current databases; no clear role in cancer, inflammation, or neurological disease)
Beyond the preview
Go deeper on Janus kinase and microtubule-interacting protein 3 (JAKMIP3).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Janus kinase and microtubule-interacting protein 3 (JAKMIP3).